These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14573419)

  • 1. Characterization of breast lesions with proton MR spectroscopy.
    Yeh ED
    AJR Am J Roentgenol; 2003 Nov; 181(5):1273-4. PubMed ID: 14573419
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors.
    Tse GM; Cheung HS; Pang LM; Chu WC; Law BK; Kung FY; Yeung DK
    AJR Am J Roentgenol; 2003 Nov; 181(5):1267-72. PubMed ID: 14573418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic factors of breast cancer].
    Tang P; Wei B; Yang WJ; Liu YS; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):73-6. PubMed ID: 21426799
    [No Abstract]   [Full Text] [Related]  

  • 4. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is breast tumor progression really linear?
    Polyak K
    Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
    Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE
    West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous lesions of the breast. A pathological continuum.
    Weaver MG; Abdul-Karim FW; al-Kaisi N
    Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein expression in invasive and in situ breast carcinomas.
    Gallicchio LM; Flaws JA; Fowler BA; Ioffe OB
    Cancer Detect Prev; 2005; 29(4):332-7. PubMed ID: 16122884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence re: Jimenez RE, Wallis T, Tabasczka P, Visscher DW. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2000;13:37-45.
    Hugh J; Barley R; Dabbagh L
    Mod Pathol; 2001 Mar; 14(3):263. PubMed ID: 11266538
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
    Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ within phyllodes tumour: a rare occurrence.
    Lim SM; Tan PH
    Pathology; 2005 Oct; 37(5):393-6. PubMed ID: 16194856
    [No Abstract]   [Full Text] [Related]  

  • 15. The routine immunohistochemical evaluation in Paget disease of the nipple.
    Marczyk E; Kruczak A; Ambicka A; Mularz K; Harazin-Lechowska A; Moskal J; Sokołowski A; Mituś J; Ryś J
    Pol J Pathol; 2011 Dec; 62(4):229-35. PubMed ID: 22246908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Β-catenin expression in in situ and infiltrative ductal carcinomas of the breast.
    Karabacak T; Eğılmez R; Arpaci RB; Pfeiffer ES
    Turk Patoloji Derg; 2011; 27(3):185-8. PubMed ID: 21935866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
    Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM; Cher-Siangang P; Tan PH
    Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.